X T L Biopharmaceuticals reported $166K in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 666K 304K Jun/2026
Bioline Rx USD 16.35M 5.23M Jun/2026
Teva Pharmaceutical Industries USD 14.6B 842M Sep/2026
X T L Biopharmaceuticals USD 166K 367K Dec/2025